Prostate apoptosis response-4 (Par-4): an emerging target for Alzheimer’s and Parkinson’s diseases and stroke

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.4, Iss.1, 2000-02, pp. : 51-63

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Translational Shift of HSP90 as a Novel Therapeutic Target from Cancer to Neurodegenerative Disorders: An Emerging Trend in the Cure of Alzheimer's and Parkinson's Diseases

Current Drug Metabolism, Vol. 18, Iss. 9, 2017-12 ,pp. : 868-876

Bentham Science Publishers

Access to resources Recommend Favorite

SMi 4th Annual Conference on Neurodegenerative Disorders: a focus on Alzheimer’s and Parkinson’s disease

By O’Neill Michael J

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 10, 2004-10 ,pp. : 1369-1373

Informa Healthcare

Access to resources Recommend Favorite

Aquaporin 4 in Astrocytes is a Target for Therapy in Alzheimer's Disease

Current Pharmaceutical Design, Vol. 23, Iss. 33, 2018-01 ,pp. : 4948-4957

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Drug Delivery Systems for Releasing Growth Factors to the CNS: Focus on Alzheimer’s and Parkinson’s Diseases

Mini Reviews in Medicinal Chemistry, Vol. 14, Iss. 7, 2014-06 ,pp. : 557-566

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances on the Role of Neurogenesis in the Adult Brain: Therapeutic Potential in Parkinson's and Alzheimer's Diseases

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 16, Iss. 7, 2017-10 ,pp. : 740-748

Bentham Science Publishers

Access to resources Recommend Favorite